Neuren Media and Analyst Coverage, page-12

Potstock/Hottod I've just listened again - timestamp approx: 34:40 there is a question and Jon mentions that he hasn't specifically detailed milestone trigger events and that he might be able to in the future, with Acadia's approval. MST and BP have made educated guesses perhaps? I'm back leaning towards NDA approval as the first trigger - which I prefer - which will be later in the year, and give the NNZ 2591 Trials to come into the valuation mix with any positive outcomes. It's a bit of an unknown just yet.